Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance.

Journal of thrombosis and haemostasis : JTH - 1 Jul 2005

Bodin L, Horellou M H, Flaujac C, Loriot M A, Samama M M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance
Share to Exons
Share to International Normalized Ratio
Share to Mixed Function Oxygenases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Time Factors

Share to Vitamin K

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 15978113
DOI: 10.1111/j.1538-7836.2005.01449.x

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance.PMID 15978113Read ↗

A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme.Semantic proximity Read ↗

Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment.Semantic proximity Read ↗

A vitamin K epoxide reductase complex subunit 1 mutation in an Irish patient with warfarin resistance.Semantic proximity Read ↗

VKORC1 mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity.Semantic proximity Read ↗

Genetic causes of resistance to vitamin K antagonists in Polish patients: a novel p.Ile123Met mutation in VKORC1 gene.Semantic proximity Read ↗

Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1.Semantic proximity Read ↗

Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfacesSemantic proximity Read ↗

VKORC1 pharmacogenomics summary.Semantic proximity Read ↗

Identification of VKORC1 genotype leading to resistance to tecarfarin.Semantic proximity Read ↗

VKORC1 mutations in patients with partial resistance to phenprocoumon.Semantic proximity Read ↗

Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition.Semantic proximity Read ↗

A new VKORC1 allelic variant (p.Trp59Arg) in a patient with partial resistance to acenocoumarol and phenprocoumon.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.